Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.\new Filed Acc 0001493152-26-039399

EXEC. CHAIR & PRINCIPAL OFF bought 2,700 shares at $0.35 ($945)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF 2026-08-19 Purchase +2,700 $0.35 $945 36,899 D: show line 1 in the form
Open-market purchases · 2,700 sh · avg $0.35 · $945
Loading xslF345X06/ownership.xml…